Taysha Gene Therapies (TSHA) Revenue (2023 - 2025)
Taysha Gene Therapies (TSHA) posted Revenue of $1.2 million for Q4 2025, down 38.97% sequentially from $2.0 million in Q2 2025, and down 40.06% YoY from $2.0 million in Q4 2024.
Taysha Gene Therapies (TSHA) Revenue (2023 - 2025) Analysis & Trends
Taysha Gene Therapies has reported Revenue for 3 years, with the latest figure at $1.2 million in Q4 2025.
- Quarterly Revenue fell 40.06% year-over-year to $1.2 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $3.2 million (down 55.73% YoY) and the FY2025 annual result came in at $5.5 million, down 34.0% from the prior year.
- Revenue declined to $1.2 million in Q4 2025 per TSHA's latest filing, from $2.0 million in the prior quarter.
- Over five years, Revenue peaked at $4.7 million in Q3 2023 and troughed at $1.1 million in Q2 2024.
- A 3-year average of $2.7 million and a median of $2.3 million in 2025 frame the typical range for Revenue.
- The sharpest annual moves came in 2024 and 2025: Revenue slumped 62.33% in 2024, then surged 78.6% in 2025.
- Over 3 years, Revenue stood at $3.6 million in 2023, then tumbled by 43.9% to $2.0 million in 2024, then sank by 40.06% to $1.2 million in 2025.
- According to Business Quant data, Revenue over the past three periods registered $1.2 million, $2.0 million, and $2.3 million for Q4 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Taysha Gene Therapies | 1.94 Bn | 1.94 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.21 Mn |
| Jun 30, 2025 | 1.99 Mn |
| Mar 31, 2025 | 2.30 Mn |
| Dec 31, 2024 | 2.02 Mn |
| Sep 30, 2024 | 1.79 Mn |
| Jun 30, 2024 | 1.11 Mn |
| Mar 31, 2024 | 3.41 Mn |
| Dec 31, 2023 | 3.60 Mn |
| Sep 30, 2023 | 4.75 Mn |
| Jun 30, 2023 | 2.40 Mn |
| Mar 31, 2023 | 4.71 Mn |